Increased serum angiotensin-converting enzyme activity and plasma angiotensin II levels during pregnancy and postpartum in the diabetic rat

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 2, Issue 3, 2001, Pages 193-198

  Van Dijk, David Jonathan ^a   Boner, Geoffrey ^a   Giler, Shaul ^a,b   Erman, Arie ^a,c  

^a Inst Hypertension and Kidney Dis   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

Author keywords

Angiotensin; Angiotensin converting enzyme; Diabetes mellitus; Insulin; Kininase II; Pregnancy

Indexed keywords

ANGIOTENSIN II; ANTIDIABETIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; INSULIN;

ANIMAL; ARTICLE; BLOOD; BREEDING; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; FEMALE; KIDNEY; LUNG; METABOLISM; ORGAN SIZE; PATHOLOGY; PREGNANCY; PREGNANCY DIABETES MELLITUS; PROTEINURIA; PUERPERIUM; RAT; REFERENCE VALUE; URINE; UTERUS; WISTAR RAT;

ANGIOTENSIN II; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; HYPOGLYCEMIC AGENTS; INSULIN; KIDNEY; LUNG; ORGAN SIZE; PEPTIDYL-DIPEPTIDASE A; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY, ANIMAL; PROTEINURIA; RATS; RATS, WISTAR; REFERENCE VALUES; UTERUS;

EID: 0035468178     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2001.027     Document Type: Article

References (24)

1. August P, Sealy JE. The renin-angiotensin system in normal and hypertensive pregnancy and in ovarian function. In: Laragh JM and Brenner BM (eds.). Hypertension: Pathology Diagnosis and Management. New York: Raven Press, 1990;1761-78.
2. Skinner S. The renin system in fertility and normal human pregnancy. In:Robertson JIS and Nicolls MG (eds.). The Renin-Angiotensin System. London: Gower Medical Publishing, 1993;1-16.
3. Derkx FHM, Stuenk C, Schalekamp MPA, Visser W, Huisveld IH, Schalekamp MADH. Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives J Clin Endocrinol Metabolism 1986;63:1008-15.
4. Recce EA, Coustan ER, Hayslett JP. Diabetic nephropathy: pregnancy performance and fetomaternal outcome. Am J Obstet Gynecol 1988;59:56-66.
5. van Dyk DJ, Erman A, Erman T, Chen-Gal B, Sulkes J, Boner G. Increased serum angiotensin converting enzyme activity in type I insulin dependent diabetes mellitus: Its relation to metabolic control and diabetic complications. Eur J Clin Invest 1994;24:463-7.
6. Erman A, van Dyk DJ, Chen-Gal B et al. Angiotensin converting enzyme activity in the serum, lung and kidney of diabetic rats. Eur J Clin Invest 1993;23:615-20.
7. Hod M, van Dijk DJ, Karp M et al. Diabetic nephropathy and pregnancy: the effect of ACE inhibitors prior to pregnancy on fetomaternal outcome. Nephrol Dial Transplant 1995;10:2328-33.
8. Leehy DJ, Signh AK, Alavi N, Singh R. Role of angiotensin II in diabetic nephropathy. Kidney Int 2000; 58 (suppl 77): S93-S98.
9. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin reagent. J Biol Chem 1951;193: 265-75.
10. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing of protein-dye binding. Anal Biochem 1976;72:248-54.
11. Chirstiansen T, Stodklide-Jorgensen H, Klebe JB, Flyvberg A. Changes in kidney volume during pregnancy in non-diabetic and diabetic rats measured by magnetic resonance imaging. Exp Nephrol 1998;6:302-6.
12. Valentovic MA, Elliott CW, Ball JB. The effect of streptozotocin-induced diabetes and insulin treatment on angiotensin converting enzyme activity. Res Comm Chem Pathol Pharmacol 1987;58:27-38.
13. Lieberman J, Sastre A. Serum angiotensin-converting enzyme: elevation in diabetes mellitus. Ann Int Med 1980; 93:825-6.
14. Parente JV, Frances JG, Greene LJ. Angiotensin convening enzyme: serum levels during normal pregnancy. Am J Obstet Gynecol 1979;135:586-91.
15. Dux S, Yaron A, Carmel A, Rosenfeld JB. Renin, aldosterone, and serum-converting enzyme activity during normal and hypertensive pregnancy. Gynecol Obstet Invest 1984;17: 252-4.
16. Brown L, Wall D, Marchant C, Sernia C. Tissue-specific changes in angiotensin II receptors in streptozotocin-diabetic rats. J Endocrinol 1997;154:355-62.
17. Erdos EG. Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension 1990;16:363-70.
18. Campbell DJ. Circulating and tissue angiotensin systems. J Clin Invest 1987; 79:1-7.
19. Erman A, Winkler J, Chen-Gal B et al. Inhibition of angiotensin converting enzyme by ramipril in serum and tissue of man. J Hypertens 1991;9:1057-62.
20. Anderson S, Jung FF, Ingelfinger JR. Renal renin-angiotensin system in diabetes:functional, immunohistochemical, and molecular biological correlation. Am J Physiol 1993; 265:F477-86.
21. Ziyadeh FN, Goldfarb S, Kern EFO. Contemporary issues in nephrology. In: Brenner BM and Stein JH (eds). The Kidney in Diabetes Mellitus. New York: Churchill Livingstone, 1989;87-113.
22. Rabkin R, Shecter P, Dong Shi J, Boner G. Protein turnover in the hypertrophying kidney. Miner Electrolyte Metab 1996; 22:153-6.
23. Defendini R, Zimmerman EA, Weare JA, Alhene-Glas F, Erdos EA. Angiotensin-converting enzyme in epithelial and neuroepithelial cells. Neuroendocrinol 1983;37:32-40.
24. Bakris GL, Akerstrom V, Re RN. Insulin, angiotensin II antagonist and converting enzyme inhibition: effect on human mesangial mitogenicity and endothelin. Hypertension 1991;3:326-31.